Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 17 studies | 30% ± 13% | |
endothelial cell | 11 studies | 30% ± 12% | |
smooth muscle cell | 11 studies | 29% ± 10% | |
fibroblast | 10 studies | 23% ± 7% | |
myofibroblast cell | 8 studies | 37% ± 13% | |
capillary endothelial cell | 7 studies | 36% ± 10% | |
connective tissue cell | 5 studies | 28% ± 5% | |
glomerular endothelial cell | 4 studies | 42% ± 7% | |
luminal hormone-sensing cell of mammary gland | 4 studies | 42% ± 3% | |
abnormal cell | 3 studies | 34% ± 13% | |
neural crest cell | 3 studies | 44% ± 19% | |
glial cell | 3 studies | 32% ± 24% | |
neuron | 3 studies | 56% ± 23% |
Insufficient scRNA-seq data for expression of TBX3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 19427.25 | 245 / 245 | 100% | 166.13 | 502 / 502 |
breast | 100% | 8707.93 | 458 / 459 | 85% | 73.25 | 955 / 1118 |
thymus | 100% | 12529.18 | 653 / 653 | 85% | 105.63 | 515 / 605 |
bladder | 100% | 12325.57 | 21 / 21 | 69% | 70.54 | 349 / 504 |
adrenal gland | 100% | 38000.26 | 258 / 258 | 65% | 124.24 | 150 / 230 |
intestine | 93% | 2064.15 | 899 / 966 | 55% | 17.09 | 291 / 527 |
skin | 99% | 3957.82 | 1796 / 1809 | 43% | 18.97 | 203 / 472 |
liver | 99% | 3531.50 | 223 / 226 | 43% | 22.69 | 175 / 406 |
uterus | 100% | 6958.89 | 170 / 170 | 38% | 16.50 | 173 / 459 |
lung | 100% | 7721.04 | 577 / 578 | 23% | 5.80 | 270 / 1155 |
ovary | 100% | 9884.01 | 180 / 180 | 11% | 2.61 | 49 / 430 |
ureter | 0% | 0 | 0 / 0 | 100% | 77.42 | 1 / 1 |
adipose | 99% | 2953.69 | 1190 / 1204 | 0% | 0 | 0 / 0 |
kidney | 90% | 1864.58 | 80 / 89 | 6% | 2.05 | 56 / 901 |
esophagus | 48% | 687.34 | 694 / 1445 | 43% | 13.46 | 79 / 183 |
stomach | 38% | 536.48 | 136 / 359 | 46% | 12.55 | 131 / 286 |
spleen | 83% | 1485.55 | 199 / 241 | 0% | 0 | 0 / 0 |
muscle | 80% | 1194.00 | 641 / 803 | 0% | 0 | 0 / 0 |
heart | 72% | 1221.65 | 624 / 861 | 0% | 0 | 0 / 0 |
pancreas | 5% | 57.21 | 17 / 328 | 29% | 9.92 | 51 / 178 |
blood vessel | 20% | 259.04 | 263 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 16% | 3.05 | 7 / 45 |
brain | 8% | 115.31 | 210 / 2642 | 2% | 0.91 | 15 / 705 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.46 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046884 | Biological process | follicle-stimulating hormone secretion |
GO_0030879 | Biological process | mammary gland development |
GO_0003151 | Biological process | outflow tract morphogenesis |
GO_0001708 | Biological process | cell fate specification |
GO_0030540 | Biological process | female genitalia development |
GO_0001701 | Biological process | in utero embryonic development |
GO_0003167 | Biological process | atrioventricular bundle cell differentiation |
GO_0003272 | Biological process | endocardial cushion formation |
GO_0035136 | Biological process | forelimb morphogenesis |
GO_0060444 | Biological process | branching involved in mammary gland duct morphogenesis |
GO_0001947 | Biological process | heart looping |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0009887 | Biological process | animal organ morphogenesis |
GO_0045662 | Biological process | negative regulation of myoblast differentiation |
GO_0061635 | Biological process | regulation of protein complex stability |
GO_0042733 | Biological process | embryonic digit morphogenesis |
GO_0008595 | Biological process | anterior/posterior axis specification, embryo |
GO_2000648 | Biological process | positive regulation of stem cell proliferation |
GO_1905222 | Biological process | atrioventricular canal morphogenesis |
GO_1905072 | Biological process | cardiac jelly development |
GO_0072089 | Biological process | stem cell proliferation |
GO_0072105 | Biological process | ureteric peristalsis |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0010159 | Biological process | specification of animal organ position |
GO_0060923 | Biological process | cardiac muscle cell fate commitment |
GO_0060931 | Biological process | sinoatrial node cell development |
GO_0035115 | Biological process | embryonic forelimb morphogenesis |
GO_0035116 | Biological process | embryonic hindlimb morphogenesis |
GO_0060317 | Biological process | cardiac epithelial to mesenchymal transition |
GO_0048332 | Biological process | mesoderm morphogenesis |
GO_0006351 | Biological process | DNA-templated transcription |
GO_0030857 | Biological process | negative regulation of epithelial cell differentiation |
GO_0060021 | Biological process | roof of mouth development |
GO_0061017 | Biological process | hepatoblast differentiation |
GO_0060596 | Biological process | mammary placode formation |
GO_0048752 | Biological process | semicircular canal morphogenesis |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0030539 | Biological process | male genitalia development |
GO_0032275 | Biological process | luteinizing hormone secretion |
GO_0019827 | Biological process | stem cell population maintenance |
GO_0051145 | Biological process | smooth muscle cell differentiation |
GO_2000137 | Biological process | negative regulation of cell proliferation involved in heart morphogenesis |
GO_0060412 | Biological process | ventricular septum morphogenesis |
GO_0001568 | Biological process | blood vessel development |
GO_2000737 | Biological process | negative regulation of stem cell differentiation |
GO_0036302 | Biological process | atrioventricular canal development |
GO_0001501 | Biological process | skeletal system development |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0090398 | Biological process | cellular senescence |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0031647 | Biological process | regulation of protein stability |
GO_0045787 | Biological process | positive regulation of cell cycle |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0021761 | Biological process | limbic system development |
GO_0005929 | Cellular component | cilium |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TBX3 |
Protein name | T-box transcription factor TBX3 (T-box protein 3) |
Synonyms | |
Description | FUNCTION: Transcriptional repressor involved in developmental processes . Binds to the palindromic T site 5'-TTCACACCTAGGTGTGAA-3' DNA sequence, or a half-site, which are present in the regulatory region of several genes . Probably plays a role in limb pattern formation . Required for mammary placode induction, and maintenance of the mammary buds during development (By similarity). Involved in branching morphogenesis in both developing lungs and adult mammary glands, via negative modulation of target genes; acting redundantly with TBX2 (By similarity). Required, together with TBX2, to maintain cell proliferation in the embryonic lung mesenchyme; perhaps acting downstream of SHH, BMP and TGFbeta signaling (By similarity). Involved in modulating early inner ear development, acting independently of, and also redundantly with, TBX2 in different subregions of the developing ear (By similarity). Acts as a negative regulator of PML function in cellular senescence . . |
Accessions | ENST00000257566.7 [O15119-1] O15119 ENST00000349155.7 [O15119-2] |